Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis
Open Access
- 15 February 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22229
Abstract
Euglycemic diabetic keto acidosis (eu-DKA) is a rare but life-threatening metabolic complication associated with sodium-glucose cotransporter-2 (SGLT-2) inhibitor therapy, especially in the setting of extreme physical stress. Due to no apparent hyperglycemia, the significant risk of delayed diagnosis or misdiagnosis exists within patients. Herein, we report a novel case of dapagliflozin-associated eu-DKA with unusual presentation. A 57-year-old female with a six-year history of type 2 diabetes mellitus (DM), for which metformin and dapagliflozin were prescribed, developed severe abdominal pain and signs of acute peritonitis without obvious hyperglycemia after distal pancreatectomy. Based on CT scan and laboratory studies, gastrointestinal tract perforation was suspected but was excluded during laparotomy. Severe metabolic acidosis and strong positive urine ketone indicated diabetic keto acidosis. The patient recovered after active therapy with an intravenous insulin infusion, antibiotics and correction of hypotension, electrolyte imbalance and acidosis. This case provides a new reference for clinicians and surgeons to be concerned with eu-DKA with severe abdominal pain as the main symptom.Keywords
This publication has 12 references indexed in Scilit:
- Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitusMedicine, 2020
- Dapagliflozin-induced Late-onset Euglycemic Diabetic KetoacidosisCureus, 2019
- Dapagliflozin (SGLT2-i) induced euglycaemic diabetic ketoacidosisBMJ Case Reports, 2019
- Dapagliflozin: A Review in Type 2 DiabetesDrugs, 2019
- Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case ReportThe Journal of Emergency Medicine, 2018
- The renal effects of SGLT2 inhibitors and a mini-review of the literatureTherapeutic Advances in Endocrinology and Metabolism, 2016
- Gastric Mucosal Petechial Hemorrhages (Wischnewsky Lesions), Hypothermia, and Diabetic KetoacidosisAmerican Journal of Forensic Medicine & Pathology, 2016
- SGLT2 Inhibitors May Predispose to KetoacidosisThe Journal of Clinical Endocrinology & Metabolism, 2015
- Dapagliflozin: A Novel Sodium‐Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes MellitusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012
- Association of Diabetic Ketoacidosis and Acute Pancreatitis: Observations in 100 Consecutive Episodes of DkaAmerican Journal of Gastroenterology, 2000